Worldwide Clinical Trials Adopts ClinSpark

The Foundry Health team is excited to share another ClinSpark success story. Worldwide Clinical Trials (Worldwide), an award-winning, full-service, midsize, global contract research organization has recently announced its successful implementation of ClinSpark, the eSource platform for Phase I clinical trial automation.

“ClinSpark gives me instant access to the critical information required to monitor the progress of our trials – anywhere I can access the internet. We are improving logistics, patient communications and data reporting, all of which are critical factors in keeping trials running smoothly and efficiently.”

George J. Atiee, M.D., Vice President, Medical and Clinical Lab Director, for Worldwide

Worldwide has completed more than 40 studies to date on the ClinSpark platform.

“The positive feedback that we receive from happy Worldwide staff and the benefits they realize from having a much more efficient dataflow is highly motivating to our team. It adds to our commitment to keep further developing the industry’s leading Phase I eSource platform.”

Brock Heinz, CEO of Foundry Health

If you have questions about ClinSpark, please reach out to us via our Contact Us page.